RXRXRecursion Pharmaceuticals, Inc.

$3.48

Who owns RXRX

331 institutions reported holding RXRX for 2026Q1, together 64% of the company, more than the 331 a quarter earlier.

331

Institutions reporting a position · as of 2026Q1 · up from 331 the quarter before

Shares held by institutions
336.1M

Shares held by institutions · 64% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.03B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
35%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
20
New positions
52
Positions exited
57
Added to
131
Reduced
77
Top 10 holdersof the company
44%
Institutional ownership by quarter, 2021Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1331336.1M$1.03B
2025Q4331324.2M$1.33B
2025Q3319324.1M$1.58B
2025Q2329310.0M$1.57B
2025Q1330306.8M$1.62B
2024Q4313304.7M$2.06B
2024Q3266264.4M$1.76B
2024Q2268251.9M$1.89B
2024Q1246212.9M$2.12B
2023Q4198206.6M$2.04B
2023Q3190152.3M$1.16B
2023Q2156127.5M$952M
2023Q1156126.1M$841M
2022Q4143123.7M$954M
2022Q3145113.7M$1.21B
2022Q2132106.5M$861M
Largest reported holders, 2026Q1
HolderShares% of companyValue
VANGUARD GROUP INC49.3M9.3%$151M
BlackRock Inc.43.2M8.2%$133M
ARK Investment Management LLC40.2M7.6%$123M
STATE STREET CORP28.5M5.4%$87M
BAILLIE GIFFORD & CO23.7M4.5%$73M
SOFTBANK GROUP CORP13.6M2.6%$42M
GEODE CAPITAL MANAGEMENT LLC12.3M2.3%$38M
MIC Capital Management UK LLP9.6M1.8%$30M
GOLDMAN SACHS GROUP INC6.1M1.1%$19M
Data Collective IV GP, LLC5.9M1.1%$18M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…